IPF affects the tissue surrounding the air sacs, or alveoli, in the lungs. This condition develops when lung tissue becomes ...

Abu Dhabi-based global healthcare giant M42 is at the forefront of transforming healthcare delivery by leveraging ...

Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who suffer with it. And, as University of South Florida pulmonologist Dr. Jose ...

In the midst of pandemic upheaval, researchers have gained fundamental insights about how the body fends off infections.

I don’t think proteomics will win over genomics," Sanghera said. "They go hand-in-glove. We’ve been overly focused [on genomics], and now we’re going to see an emergence of proteomics. And when the ...

Findings reveal fluoxetine's weak antiviral effects in COVID-19, with no significant benefits in symptom resolution compared to other antiviral treatments.

Pulmonary fibrosis in patients with COVID-19 tends to resolve, while idiopathic pulmonary fibrosis always progresses.

AI is redefining clinical care by enhancing human expertise across diagnostics, care coordination and patient monitoring.

"Since the outbreak of COVID-19 five years ago, China has shared information on the outbreak and genome sequence of the virus with WHO and the international community at the earliest time possible ...

The study also evaluated the effectiveness of public health measures, such as travel restrictions, in reducing the spread ...